(Q62025973)
Statements
A Phase 1a, Double-Blind, Placebo-Controlled, Single-Ascending Dose Study of SYNT001 in Healthy Volunteers (English)
0 references
17 August 2016
0 references
13 April 2017
0 references
31
0 references
18 year
0 references
55 year
0 references